This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA. 2015;314(17):1818-31.KantorEDRehmCDHaasJSChanATGiovannucciELTrends in Prescription Drug Use Among Adults in the United States From 1999-2012JAMA20153141718183110.1001/jama.2015.13766475216926529160Search in Google Scholar
LAREB DD. Update overview 2019 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumab.: LAREB; 2019 https://databankws.lareb.nl/Downloads/Signals_2019_DOACs_update_overview%202019.pdfLAREB DD. Update overview 2019 of reports on direct oral anticoagulants (DOACs) and the antidote idarucizumabLAREB2019https://databankws.lareb.nl/Downloads/Signals_2019_DOACs_update_overview%202019.pdfSearch in Google Scholar
Lepore ML. Upper airway obstruction induced by warfarin sodium. Arch Otolaryngol. 1976;102(8):505-6.LeporeMLUpper airway obstruction induced by warfarin sodiumArch Otolaryngol19761028505610.1001/archotol.1976.00780130099015942329Search in Google Scholar
Gonzalez-Garcia R, Schoendorff G, Munoz-Guerra MF, Rodriguez-Campo FJ, Naval-Gias L, Sastre-Perez J. Upper airway obstruction by sublingual haematoma : a complication of anticoagulation therapy with acenocoumarol. Am J Otolaryngol. 2006;27(2):129-32.Gonzalez-GarciaRSchoendorffGMunoz-GuerraMFRodriguez-CampoFJNaval-GiasLSastre-PerezJUpper airway obstruction by sublingual haematoma : a complication of anticoagulation therapy with acenocoumarolAm J Otolaryngol20062721293210.1016/j.amjoto.2005.07.01316500477Search in Google Scholar
Cashman E, Shandilya M, Amin M, Hughes J, Walsh M. Warfarin-induced sublingual haematoma mimicking Ludwig angina: Conservative management of a potentially life-threatening condition. Ear Nose Throat J. 2011;90(2):E1.CashmanEShandilyaMAminMHughesJWalshMWarfarin-induced sublingual haematoma mimicking Ludwig angina: Conservative management of a potentially life-threatening conditionEar Nose Throat J2011902E110.1177/01455613110900020821328214Search in Google Scholar
Frohna WJ, Lowery RC, Jr., Pita F. Lingual and sublingual haematoma causing upper airway obstruction. J Emerg Med. 2012;43(6):1075-6.FrohnaWJLoweryRC Jr.PitaFLingual and sublingual haematoma causing upper airway obstructionJ Emerg Med20124361075610.1016/j.jemermed.2011.05.07522018982Search in Google Scholar
Puri A, Nusrath MA, Harinathan D, Lyall J. Massive sublingual haematoma secondary to anticoagulant therapy complicated by a traumatic denture: a case report. J Med Case Rep. 2012;6:105.PuriANusrathMAHarinathanDLyallJMassive sublingual haematoma secondary to anticoagulant therapy complicated by a traumatic denture: a case reportJ Med Case Rep2012610510.1186/1752-1947-6-105333951822490365Search in Google Scholar
Lovallo E, Patterson S, Erickson M, Chin C, Blanc P, Durrani TS. When Is “Pseudo-Ludwig’s Angina” Associated With Coagulopathy Also a “Pseudo” Hemorrhage? J Investig Med High Impact Case Rep. 2013;1(2):2324709613492503.LovalloEPattersonSEricksonMChinCBlancPDurraniTSWhen Is “Pseudo-Ludwig’s Angina” Associated With Coagulopathy Also a “Pseudo” Hemorrhage?J Investig Med High Impact Case Rep201312232470961349250310.1177/2324709613492503452879526425576Search in Google Scholar
Pathak R, Supplee S, Aryal MR, Karmacharya P. Warfarin induced sublingual haematoma : a Ludwig angina mimic. Am J Otolaryngol. 2015;36(1):84-6.PathakRSuppleeSAryalMRKarmacharyaPWarfarin induced sublingual haematoma : a Ludwig angina mimicAm J Otolaryngol201536184610.1016/j.amjoto.2014.08.00825301667Search in Google Scholar
Almegren M. Reversal of direct oral anticoagulants. Vasc Health Risk Manag. 2017;13:287-92.AlmegrenMReversal of direct oral anticoagulantsVasc Health Risk Manag2017132879210.2147/VHRM.S138890552909328769570Search in Google Scholar
Palaiodimos L, Miles J, Kokkinidis DG, Barkolias C, Jonnalagadda AK, Papaconstantinou D, et al. Reversal of Novel Anticoagulants in Emergent Surgery and Trauma: A Comprehensive Review and Proposed Management Algorithm. Curr Pharm Des. 2018;24(38):4540-53.PalaiodimosLMilesJKokkinidisDGBarkoliasCJonnalagaddaAKPapaconstantinouDet alReversal of Novel Anticoagulants in Emergent Surgery and Trauma: A Comprehensive Review and Proposed Management AlgorithmCurr Pharm Des2018243845405310.2174/138161282566618122615062930585542Search in Google Scholar
Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014;63(20):2141-7.HylekEMHeldCAlexanderJHLopesRDDe CaterinaRWojdylaDMet alMajor bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesJ Am Coll Cardiol201463202141710.1016/j.jacc.2014.02.54924657685Search in Google Scholar
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-104.GiuglianoRPRuffCTBraunwaldEMurphySAWiviottSDHalperinJLet alEdoxaban versus warfarin in patients with atrial fibrillationN Engl J Med201336922209310410.1056/NEJMoa131090724251359Search in Google Scholar
Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, et al. Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation. 2013;128(21):2325-32.MajeedAHwangHGConnollySJEikelboomJWEzekowitzMDWallentinLet alManagement and outcomes of major bleeding during treatment with dabigatran or warfarinCirculation20131282123253210.1161/CIRCULATIONAHA.113.00233224081972Search in Google Scholar
Cowell RP. Direct oral anticoagulants: integration into clinical practice. Postgrad Med J. 2014;90(1067):529-39.CowellRPDirect oral anticoagulants: integration into clinical practicePostgrad Med J20149010675293910.1136/postgradmedj-2013-132474414542025012514Search in Google Scholar
Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, et al. A specific antidote for dabigatran: functional and structural characterization. Blood. 2013;121(18):3554-62.SchieleFvan RynJCanadaKNewsomeCSepulvedaEParkJet alA specific antidote for dabigatran: functional and structural characterizationBlood20131211835546210.1182/blood-2012-11-46820723476049Search in Google Scholar
Greinacher A, Thiele T, Selleng K. Reversal of anticoagulants: an overview of current developments. Thromb Haemost. 2015;113(5):931-42.GreinacherAThieleTSellengKReversal of anticoagulants: an overview of current developmentsThromb Haemost201511359314210.1160/TH14-11-098225832311Search in Google Scholar
Karmacharya P, Pathak R, Ghimire S, Shrestha P, Ghimire S, Poudel DR, et al. Upper Airway Haematoma Secondary to Warfarin Therapy: A Systematic Review of Reported Cases. N Am J Med Sci. 2015;7(11):494-502.KarmacharyaPPathakRGhimireSShresthaPGhimireSPoudelDRet alUpper Airway Haematoma Secondary to Warfarin Therapy: A Systematic Review of Reported CasesN Am J Med Sci201571149450210.4103/1947-2714.170606468380426713297Search in Google Scholar
